Get Involved

Genetic Determinants of Kawasaki Disease

Genetic Determinants of Kawasaki Disease

Kawasaki disease is an illness affecting young children and may cause many symptoms including fever, rash, red eyes, enlarged glands in the neck, and redness of the tongue and lips.  In some children, the blood vessels supplying the heart (the coronary arteries) are also damaged.

We plan to investigate Kawasaki disease by looking at the variation in some of the genes involved in the immune system and also those involved in the functioning of the circulation and heart. To investigate this variation we will look at DNA from both parents (if possible) and the person who suffered from Kawasaki disease.

Please contact Fiona to find out more –



Clinical Trials in Research for Children

Select a trial from the list below to find out more about what it’s all about and how you can get involved in helping others.


This research study aims to find the relationship between the gene mutations associated with ARCI and the observable characteristics and traits of individuals affected by ARCI.


The British Orthopaedic Surgery Surveillance (BOSS) Study is a nationwide reporting mechanism to determine the epidemiology and outcomes in rare orthopaedic diseases.


Should children and young people with long lasting seizures be treated with a medicine called phenytoin or levetiracetam in an emergency setting.


A trial to assess the role of intravenous immunoglobulin in the management of children with encephalitis

Genetic Determinants of Kawasaki Disease

An investigation into Kawasaki Disease by looking at the variation of genes involved in the immune system.


The purpose of this study is to test the effectiveness of home-based light therapy using hand-held units and topical steroid for the treatment of vitiligo.


To evaluate the effectiveness of a six day course of daily prednisoline therapy at the time of URTI in reducing the development of subsequent nephrotic syndrome relapse in children with relapsing SSNS.

Registry (RaDaR)

An initiative by UK kidney specialists to pull together information from patients who have certain rare kidney diseases.


This study has been designed to find out whether it is better to give patients with Cystic Fibrosis antibiotics orally or intravenously.

Latest news from PPI

View all